Sellas Life Sciences Group Inc (SLS)
R&D Expenses
$20.35M
TTM · Period ending: · USD
SLS R&D Expenses
Latest reported$20.35Mperiod ending
Latest reported$20.35Mperiod ending
SLS TTM R&D Expenses ($9.30M → $20.35M)
TTM R&D Expenses
High-resolution chart · PNG
SLS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 20,347,000 | |
| 17,946,000 | |
| 16,022,000 | |
| 15,729,000 | |
| 15,875,000 | |
| 17,190,000 | |
| 19,096,000 | |
| 19,756,000 | |
| 21,207,000 | |
| 21,944,000 | |
| 24,007,000 | |
| 24,756,000 | |
| 23,225,000 | |
| 22,831,000 | |
| 20,268,000 | |
| 17,815,000 | |
| 18,074,000 | |
| 16,001,000 | |
| 15,674,000 | |
| 15,052,000 | |
| 12,878,000 | |
| 11,702,000 | |
| 9,282,000 | |
| 11,590,000 | |
| 11,022,000 | |
| 10,123,000 | |
| 10,118,000 | |
| 18,240,000 | |
| 18,161,000 | |
| 18,372,000 | |
| 18,317,000 | |
| 5,826,000 | |
| 5,057,000 | |
| 5,509,000 | |
| 6,067,000 | |
| 9,975,000 | |
| 12,648,000 | |
| 16,779,000 | |
| 19,860,000 | |
| 19,913,000 | |
| 22,029,000 | |
| 23,051,000 | |
| 23,433,000 | |
| 25,034,000 | |
| 26,319,000 | |
| 27,191,000 | |
| 28,136,000 | |
| 28,950,000 | |
| 25,558,000 | |
| 22,765,000 | |
| 21,076,000 | |
| 18,051,000 | |
| 18,587,000 | |
| 17,031,000 | |
| 15,342,000 | |
| 14,984,000 | |
| 12,182,000 | |
| 11,135,000 | |
| 9,899,000 | |
| 7,943,000 | |
| 8,512,000 | |
| 7,323,000 | |
| 7,093,000 | |
| 7,705,000 | |
| 7,860,000 | |
| 8,193,000 | |
| 7,683,000 | |
| 7,521,000 | |
| 6,546,000 | |
| 7,495,000 | |
| 7,167,000 | |
| 8,648,000 | |
| 8,555,000 | |
| 9,559,000 | |
| 9,295,000 | |
| 5,569,000 |